ICD-10 Coding for Cannabinoid Hyperemesis Syndrome(R11.2, F12.90)
Complete ICD-10-CM coding and documentation guide for Cannabinoid Hyperemesis Syndrome. Includes clinical validation requirements, documentation requirements, and coding pitfalls.
Also known as:
Related ICD-10 Code Ranges
Complete code families applicable to Cannabinoid Hyperemesis Syndrome
Code Comparison: When to Use Each Code
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| R11.2 | Nausea with vomiting, unspecified | Use when nausea and vomiting are present with a history of cannabis use. |
|
| F12.90 | Cannabis use, unspecified, uncomplicated | Use when cannabis use is present without dependence or abuse. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information: ICD-10 code for cannabinoid hyperemesis syndrome
Essential facts and insights about Cannabinoid Hyperemesis Syndrome
Primary ICD-10-CM Codes for cannabinoid hyperemesis syndrome
Decision Criteria
clinical Criteria
- Presence of nausea and vomiting with cannabis use history.
F12.90 - Cannabis use, unspecified, uncomplicated
Use when cannabis use is present without dependence or abuse.
Applicable To
- Cannabis use without complications
Excludes
- Cannabis dependence (F12.20)
Clinical Validation Requirements
- Documented cannabis use
Coding Notes
Ensure cannabis use is documented.
Ancillary Codes
Additional codes that should be used in conjunction with the main diagnosis codes when applicable.
Cannabis use, unspecified
F12.90Documentation & Coding Risks
Avoid these common documentation and coding issues when documenting Cannabinoid Hyperemesis Syndrome to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code R11.2.
Impact
Clinical: Misdiagnosis of CHS., Regulatory: Non-compliance with coding standards., Financial: Potential reimbursement issues.
Mitigation Strategy
Educate clinicians on documentation requirements.
Impact
Reimbursement: May affect DRG assignment and reimbursement., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate representation of patient condition.
Mitigation Strategy
Always pair R11.2 with an F12 code to indicate cannabis use.
Impact
Risk of audits due to missing F12 codes with R11.2.
Mitigation Strategy
Ensure all relevant codes are used and documented.
Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.
Frequently Asked Questions
Common questions about ICD-10 coding for Cannabinoid Hyperemesis Syndrome, with expert answers to help guide accurate code selection and documentation.
Documentation Templates for Cannabinoid Hyperemesis Syndrome
Use these documentation templates to ensure complete and accurate documentation for Cannabinoid Hyperemesis Syndrome. These templates include all required elements for proper coding and billing.
Emergency Department Visit for CHS
Specialty: Emergency MedicineRequired Elements
- History of cannabis use
- Nausea and vomiting symptoms
- Relief with hot showers
Example Documentation
Examples: Poor vs. Good Documentation
Poor Documentation Example
Good Documentation Example
Explanation
Need help with ICD-10 coding for Cannabinoid Hyperemesis Syndrome? Ask your questions below.